Add Company
Join Now

Engager Revenue and Competitors

License our Company Data API

RO

Location

N/A

Total Funding

HR

Industry

Estimated Revenue & Valuation

  • Engager's estimated annual revenue is currently $301.5k per year.(i)
  • Engager's estimated revenue per employee is $100,500

Employee Data

  • Engager has 3 Employees.(i)

Engager's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.4M6N/AN/AN/A
#2
$14.9M10317%N/AN/A
#3
$0.1M8-11%$7.5MN/A
#4
$4.6M420%$147MN/A
#5
$108.1M387-4%$7.5MN/A
#6
$1.7M2450%$10.9MN/A
#7
$13.3M67N/AN/AN/A
#8
$1.3M11N/AN/AN/A
#9
$3.9M28N/AN/AN/A
#10
$0.5M7N/AN/AN/A
#11
$0.7M7N/AN/AN/A
#12
$2.1M21N/AN/AN/A
#13
$23.9M119N/AN/AN/A
#14
$0.5M16-76%$15.9MN/A
#15
$0.4M6N/AN/AN/A
#16
$57.5M312-4%$97MN/A
#17
$2.1M17N/AN/AN/A
#18
$0.9M10N/AN/AN/A
#19
$5.3M46N/AN/AN/A
#20
$0.6M8N/AN/AN/A
Add Company

What Is Engager?

keywords:N/A

N/A

Total Funding

3

Number of Employees

$301.5k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Engager News

2022-04-13 - Cytovia is Empowering NK Cells and NK Engager Antibodies ...

Therefore, when necessary, Cytovia can add NK cells to its NK engager antibody therapy. The company's main program focuses on liver cancer,...

2022-04-13 - Combination gemcitabine and PD-L1xCD3 bispecific T cell ...

Combination gemcitabine and PD-L1xCD3 bispecific T cell engager (BiTE) enhances T lymphocyte cytotoxicity against cholangiocarcinoma cells.

2022-04-06 - AbCellera Presents Data on T Cell Engager Platform at AACR ...

AbCellera Presents Data on T Cell Engager Platform at AACR 2022. April 08, 2022 01:05 PM Eastern Daylight Time. VANCOUVER, British Columbia--(BUSINESS...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.2M3N/AN/A
#2
$0.2M3N/AN/A
#3
$0.2M3N/AN/A
#4
$0.2M3N/AN/A
#5
$0.4M3N/AN/A